<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37077911</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals.</ArticleTitle><Pagination><StartPage>1151780</StartPage><MedlinePgn>1151780</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1151780</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1151780</ELocationID><Abstract><AbstractText Label="BACKGROUND">Monocytes and macrophages play a pivotal role in inflammation during acute SARS-CoV-2 infection. However, their contribution to the development of post-acute sequelae of SARS-CoV-2 infection (PASC) are not fully elucidated.</AbstractText><AbstractText Label="METHODS">A cross-sectional study was conducted comparing plasma cytokine and monocyte levels among three groups: participants with pulmonary PASC (PPASC) with a reduced predicted diffusing capacity for carbon monoxide [DLCOc, &lt;80%; (PG)]; fully recovered from SARS-CoV-2 with no residual symptoms (recovered group, RG); and negative for SARS-CoV-2 (negative group, NG). The expressions of cytokines were measured in plasma of study cohort by Luminex assay. The percentages and numbers of monocyte subsets (classical, intermediate, and non-classical monocytes) and monocyte activation (defined by CD169 expression) were analyzed using flow cytometry analysis of peripheral blood mononuclear cells.</AbstractText><AbstractText Label="RESULTS">Plasma IL-1Ra levels were elevated but FGF levels were reduced in PG compared to NG. Circulating monocytes and three subsets were significantly higher in PG and RG compared to NG. PG and RG exhibited <i>higher levels of</i> CD169<sup>+</sup> monocyte counts and&#xa0;<i>higher</i>&#xa0;CD169 expression was detected in intermediate and non-classical monocytes from RG and PG than that found in NG. Further correlation analysis with CD169<sup>+</sup> monocyte subsets revealed that CD169<sup>+</sup> intermediate monocytes negatively correlated with DLCOc%, and CD169<sup>+</sup> non-classical monocytes positively correlated with IL-1&#x3b1;, IL-1&#x3b2;, MIP-1&#x3b1;, Eotaxin, and IFN-&#x3b3;.</AbstractText><AbstractText Label="CONCLUSION">This study present evidence that COVID convalescents exhibit monocyte alteration beyond the acute COVID-19 infection period even in convalescents with no residual symptoms. Further, the results suggest that monocyte alteration and increased activated monocyte subsets may impact pulmonary function in COVID-19 convalescents. This observation will aid in understanding the immunopathologic feature of pulmonary PASC development, resolution, and subsequent therapeutic interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Park, Dean, Jiyarom, Gangcuangco, Shah, Awamura, Ching, Nerurkar, Chow, Igno, Shikuma and Devendra.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Juwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dean</LastName><ForeName>Logan S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiyarom</LastName><ForeName>Boonyanudh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangcuangco</LastName><ForeName>Louie Mar</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Parthav</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awamura</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ching</LastName><ForeName>Lauren L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nerurkar</LastName><ForeName>Vivek R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Dominic C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Igno</LastName><ForeName>Fritzie</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shikuma</LastName><ForeName>Cecilia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devendra</LastName><ForeName>Gehan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care, Queen's Medical Center, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K12 HL143960</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 MD007601</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AI027757</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 GM114737</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T37 MD008636</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="Y">Monocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD169</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">monocytes</Keyword><Keyword MajorTopicYN="N">post-acute sequalae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">pulmonary sequelae</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>2</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37077911</ArticleId><ArticleId IdType="pmc">PMC10106598</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1151780</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Seery V, Raiden SC, Algieri SC, Grisolia NA, Filippo D, De Carli N, et al. . Blood neutrophils from children with covid-19 exhibit both inflammatory and anti-inflammatory markers. EBioMedicine (2021) 67:103357. doi:&#xa0;10.1016/j.ebiom.2021.103357</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103357</ArticleId><ArticleId IdType="pmc">PMC8153212</ArticleId><ArticleId IdType="pubmed">33979758</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. . Short-term and long-term rates of postacute sequelae of sars-Cov-2 infection: A systematic review. JAMA Netw Open (2021) 4(10):e2128568. doi:&#xa0;10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang DH, Roy DJ, Gu BJ, Hassett LC, McCoy RG. Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection: A state-of-the-Art review. JACC Basic Transl Sci (2021) 6(9):796&#x2013;811. doi:&#xa0;10.1016/j.jacbts.2021.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.07.002</ArticleId><ArticleId IdType="pmc">PMC8442719</ArticleId><ArticleId IdType="pubmed">34541421</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, et al. . Post-acute covid-19 syndrome. Eur Respir Rev (2022) 31:210185. doi:&#xa0;10.1183/16000617.0185-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of covid-19. Science (2022) 375(6585):1122&#x2013;7. doi:&#xa0;10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. . Hematological findings and complications of covid-19. Am J Hematol (2020) 95(7):834&#x2013;47. doi:&#xa0;10.1002/ajh.25829</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. . Complex immune dysregulation in covid-19 patients with severe respiratory failure. Cell Host Microbe (2020) 27(6):992&#x2013;1000.e3. doi:&#xa0;10.1016/j.chom.2020.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassler K, Schulte-Schrepping J, Warnat-Herresthal S, Aschenbrenner AC, Schultze JL. The myeloid cell compartment-cell by cell. Annu Rev Immunol (2019) 37:269&#x2013;93. doi:&#xa0;10.1146/annurev-immunol-042718-041728</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041728</ArticleId><ArticleId IdType="pubmed">30649988</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes. Immunity (2018) 49(4):595&#x2013;613. doi:&#xa0;10.1016/j.immuni.2018.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.10.005</ArticleId><ArticleId IdType="pubmed">30332628</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and macrophages in covid-19. Front Immunol (2021) 12:720109. doi:&#xa0;10.3389/fimmu.2021.720109</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.720109</ArticleId><ArticleId IdType="pmc">PMC8335157</ArticleId><ArticleId IdType="pubmed">34367190</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, et al. . Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe covid-19 patients. Natl Sci Rev (2020) 7(6):998&#x2013;1002. doi:&#xa0;10.1093/nsr/nwaa041</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa041</ArticleId><ArticleId IdType="pmc">PMC7108005</ArticleId><ArticleId IdType="pubmed">34676125</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J, Reusch N, Paclik D, Bassler K, Schlickeiser S, Zhang B, et al. . Severe covid-19 is marked by a dysregulated myeloid cell compartment. Cell (2020) 182(6):1419&#x2013;40.e23. doi:&#xa0;10.1016/j.cell.2020.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. . Single-cell landscape of bronchoalveolar immune cells in patients with covid-19. Nat Med (2020) 26(6):842&#x2013;4. doi:&#xa0;10.1038/s41591-020-0901-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Jiang C, Cai P, Shen Z, Sun W, Xu H, et al. . Single-cell analysis of covid-19, sepsis, and hiv infection reveals hyperinflammatory and immunosuppressive signatures in monocytes. Cell Rep (2021) 37(1):109793. doi:&#xa0;10.1016/j.celrep.2021.109793</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109793</ArticleId><ArticleId IdType="pmc">PMC8445774</ArticleId><ArticleId IdType="pubmed">34587478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann ER, Menon M, Knight SB, Konkel JE, Jagger C, Shaw TN, et al. . Longitudinal immune profiling reveals key myeloid signatures associated with covid-19. Sci Immunol (2020) 5(51). doi:&#xa0;10.1126/sciimmunol.abd6197</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd6197</ArticleId><ArticleId IdType="pmc">PMC7857390</ArticleId><ArticleId IdType="pubmed">32943497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuter M, Lee JS, Tzouvelekis A, Oldham JM, Molyneaux PL, Weycker D, et al. . Monocyte count as a prognostic biomarker in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2021) 204(1):74&#x2013;81. doi:&#xa0;10.1164/rccm.202003-0669OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0669OC</ArticleId><ArticleId IdType="pmc">PMC8437112</ArticleId><ArticleId IdType="pubmed">33434107</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott MKD, Quinn K, Li Q, Carroll R, Warsinske H, Vallania F, et al. . Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: A retrospective, multicentre cohort study. Lancet Respir Med (2019) 7(6):497&#x2013;508. doi:&#xa0;10.1016/S2213-2600(18)30508-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30508-3</ArticleId><ArticleId IdType="pmc">PMC6529612</ArticleId><ArticleId IdType="pubmed">30935881</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, et al. . Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe covid-19. Immunity (2021) 54(4):797&#x2013;814.e6. doi:&#xa0;10.1016/j.immuni.2021.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.03.005</ArticleId><ArticleId IdType="pmc">PMC7951561</ArticleId><ArticleId IdType="pubmed">33765436</ArticleId></ArticleIdList></Reference><Reference><Citation>Marais C, Claude C, Semaan N, Charbel R, Barreault S, Travert B, et al. . Myeloid phenotypes in severe covid-19 predict secondary infection and mortality: A pilot study. Ann Intensive Care (2021) 11(1):111. doi:&#xa0;10.1186/s13613-021-00896-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00896-4</ArticleId><ArticleId IdType="pmc">PMC8278374</ArticleId><ArticleId IdType="pubmed">34259942</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A, Gonzalez-Cuadrado C, Chivite-Lacaba M, Cabrera-Marante O, Laguna-Goya R, Almendro-Vazquez P, et al. . Alterations in circulating monocytes predict covid-19 severity and include chromatin modifications still detectable six months after recovery. Biomedicines (2021) 9(9). doi:&#xa0;10.3390/biomedicines9091253</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9091253</ArticleId><ArticleId IdType="pmc">PMC8471575</ArticleId><ArticleId IdType="pubmed">34572439</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, et al. . Long-term perturbation of the peripheral immune system months after sars-Cov-2 infection. BMC Med (2022) 20(1):26. doi:&#xa0;10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-Moderate sars-Cov-2 infection. Nat Immunol (2022) 23(2):210&#x2013;6. doi:&#xa0;10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, et al. . Persistence of sars cov-2 S1 protein in Cd16+ monocytes in post-acute sequelae of covid-19 (Pasc) up to 15 months post-infection. Front Immunol (2021) 12:746021. doi:&#xa0;10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. . Ers/Ats technical standard on interpretive strategies for routine lung function tests. Eur Respir J (2022) 60(1):2101499. doi:&#xa0;10.1183/13993003.01499-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01499-2021</ArticleId><ArticleId IdType="pubmed">34949706</ArticleId></ArticleIdList></Reference><Reference><Citation>SahBandar IN, Ndhlovu LC, Saiki K, Kohorn LB, Peterson MM, D'Antoni ML, et al. . Relationship between circulating inflammatory monocytes and cardiovascular disease measures of carotid intimal thickness. J Atheroscler Thromb (2020) 27(5):441&#x2013;8. doi:&#xa0;10.5551/jat.49791</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.49791</ArticleId><ArticleId IdType="pmc">PMC7242227</ArticleId><ArticleId IdType="pubmed">31588100</ArticleId></ArticleIdList></Reference><Reference><Citation>Affandi AJ, Olesek K, Grabowska J, Nijen Twilhaar MK, Rodriguez E, Saris A, et al. . Cd169 defines activated Cd14(+) monocytes with enhanced Cd8(+) T cell activation capacity. Front Immunol (2021) 12:697840. doi:&#xa0;10.3389/fimmu.2021.697840</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.697840</ArticleId><ArticleId IdType="pmc">PMC8356644</ArticleId><ArticleId IdType="pubmed">34394090</ArticleId></ArticleIdList></Reference><Reference><Citation>Doehn JM, Tabeling C, Biesen R, Saccomanno J, Madlung E, Pappe E, et al. . Cd169/Siglec1 is expressed on circulating monocytes in covid-19 and expression levels are associated with disease severity. Infection (2021) 49(4):757&#x2013;62. doi:&#xa0;10.1007/s15010-021-01606-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01606-9</ArticleId><ArticleId IdType="pmc">PMC8023546</ArticleId><ArticleId IdType="pubmed">33825125</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood (2001) 97(1):288&#x2013;96. doi:&#xa0;10.1182/blood.v97.1.288</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.v97.1.288</ArticleId><ArticleId IdType="pubmed">11133773</ArticleId></ArticleIdList></Reference><Reference><Citation>York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R. A macrophage marker, siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum (2007) 56(3):1010&#x2013;20. doi:&#xa0;10.1002/art.22382</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22382</ArticleId><ArticleId IdType="pubmed">17328080</ArticleId></ArticleIdList></Reference><Reference><Citation>Biesen R, Demir C, Barkhudarova F, Grun JR, Steinbrich-Zollner M, Backhaus M, et al. . Sialic acid-binding ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum (2008) 58(4):1136&#x2013;45. doi:&#xa0;10.1002/art.23404</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23404</ArticleId><ArticleId IdType="pubmed">18383365</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong YS, Cheng Y, Lin QS, Wu AL, Yu J, Li C, et al. . Increased expression of siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis. Rheumatol (Oxford) (2014) 53(2):250&#x2013;9. doi:&#xa0;10.1093/rheumatology/ket342</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ket342</ArticleId><ArticleId IdType="pubmed">24196391</ArticleId></ArticleIdList></Reference><Reference><Citation>Darawshy F, Abu Rmeileh A, Kuint R, Padawer D, Karim K, Fridlender Z, et al. . Residual symptoms, lung function, and imaging findings in patients recovering from sars-Cov-2 infection. Intern Emerg Med (2022) 17(5):1491&#x2013;501. doi:&#xa0;10.1007/s11739-022-02950-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-02950-w</ArticleId><ArticleId IdType="pmc">PMC8889872</ArticleId><ArticleId IdType="pubmed">35235130</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdallah SJ, Voduc N, Corrales-Medina VF, McGuinty M, Pratt A, Chopra A, et al. . Symptoms, pulmonary function, and functional capacity four months after covid-19. Ann Am Thorac Soc (2021) 18(11):1912&#x2013;7. doi:&#xa0;10.1513/AnnalsATS.202012-1489RL</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202012-1489RL</ArticleId><ArticleId IdType="pmc">PMC8641826</ArticleId><ArticleId IdType="pubmed">33872135</ArticleId></ArticleIdList></Reference><Reference><Citation>Smet J, Stylemans D, Hanon S, Ilsen B, Verbanck S, Vanderhelst E. Clinical status and lung function 10 weeks after severe sars-Cov-2 infection. Respir Med (2021) 176:106276. doi:&#xa0;10.1016/j.rmed.2020.106276</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106276</ArticleId><ArticleId IdType="pmc">PMC7701883</ArticleId><ArticleId IdType="pubmed">33278758</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Cornelissen C, Muller A, Bergs I, Marx N, et al. . Follow up of patients with severe coronavirus disease 2019 (Covid-19): Pulmonary and extrapulmonary disease sequelae. Respir Med (2020) 174:106197. doi:&#xa0;10.1016/j.rmed.2020.106197</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106197</ArticleId><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MAF, Neves P, Lima SS, Lopes JDC, Torres M, Vallinoto I, et al. . Cytokine profiles associated with acute covid-19 and long covid-19 syndrome. Front Cell Infect Microbiol (2022) 12:922422. doi:&#xa0;10.3389/fcimb.2022.922422</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Jiang X, Yang L, Chen L, Zeng X, Liu G, et al. . Sars-Cov-2-Specific immune response in covid-19 convalescent individuals. Signal Transduct Target Ther (2021) 6(1):256. doi:&#xa0;10.1038/s41392-021-00686-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00686-1</ArticleId><ArticleId IdType="pmc">PMC8261819</ArticleId><ArticleId IdType="pubmed">34234102</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. . The il-1beta, il-6, and tnf cytokine triad is associated with post-acute sequelae of covid-19. Cell Rep Med (2022) 3(6):100663. doi:&#xa0;10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandori WJ, Padgett LE, Alimadadi A, Gutierrez NA, Araujo DJ, Huh CJ, et al. . Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of Cd9(+) monocytes associated with covid-19 hospitalization. J Leukoc Biol (2022) 112(5):1053&#x2013;63. doi:&#xa0;10.1002/JLB.4COVA0122-076R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4COVA0122-076R</ArticleId><ArticleId IdType="pmc">PMC9350203</ArticleId><ArticleId IdType="pubmed">35866369</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C, Willscher E, Paschold L, Gottschick C, Klee B, Bosurgi L, et al. . Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of covid-19. J Med Virol (2023) 95(1):e28364. doi:&#xa0;10.1002/jmv.28364</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28364</ArticleId><ArticleId IdType="pmc">PMC9878213</ArticleId><ArticleId IdType="pubmed">36458566</ArticleId></ArticleIdList></Reference><Reference><Citation>Afanasieva OI, Filatova AY, Arefieva TI, Klesareva EA, Tyurina AV, Radyukhina NV, et al. . The association of lipoprotein(a) and circulating monocyte subsets with severe coronary atherosclerosis. J Cardiovasc Dev Dis (2021) 8(6). doi:&#xa0;10.3390/jcdd8060063</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd8060063</ArticleId><ArticleId IdType="pmc">PMC8228191</ArticleId><ArticleId IdType="pubmed">34206012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mule G, et al. . Female gender is associated with long covid syndrome: A prospective cohort study. Clin Microbiol Infect (2022) 28(4):611.e9&#x2013;e16. doi:&#xa0;10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long covid in non-hospitalized adults. Nat Med (2022) 28(8):1706&#x2013;14. doi:&#xa0;10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>